Synopsys stock climbs into weekend on chip rally; insider sale filing in focus

Synopsys stock climbs into weekend on chip rally; insider sale filing in focus

NEW YORK, Jan 9, 2026, 20:46 EST — Market closed

  • Synopsys climbed 2.1% on Friday, following a general upswing in chip stocks
  • A Form 4 revealed an insider sale earlier this week, executed under a pre-set trading plan
  • Coming up next: U.S. inflation figures and Synopsys’ investor conference presentation

Shares of Synopsys Inc climbed 2.1% on Friday, closing at $525.18. The chip-design software company saw a volatile start to 2026 but gained momentum with a semiconductor sector rally late in the week.

The move came as U.S. stocks hit new highs following a weaker-than-expected December jobs report, keeping hopes for rate cuts alive. Meanwhile, the PHLX semiconductor index surged to a record peak. “On the overall AI theme, investors are getting granular and picking the winners and losers in terms of sub-themes and individual names,” said Zachary Hill, head of portfolio management at Horizon Investments. 1

Synopsys traders got a new insider filing to chew on. A Form 4 revealed that Janet Lee, general counsel and corporate secretary, offloaded 250 shares at $510 each on Jan. 7. The filing noted this sale was executed under a Rule 10b5-1 plan — an automatic schedule insiders use to sell stock. 2

Rival Cadence Design Systems climbed 2.7% to $327.31. Synopsys closed the week roughly 19% under its 52-week peak of $651.73, which it reached in late July. 3

The next company-specific update will probably come from commentary rather than earnings. Back in December, Synopsys projected fiscal 2026 revenue between $9.56 billion and $9.66 billion, with first-quarter revenue expected to hit $2.365 billion to $2.415 billion. CEO Sassine Ghazi emphasized the company’s “intense focus” on growth and margins as it heads into the year. 4

During CES week in Las Vegas, Synopsys has been leveraging the event to showcase its executives to customers and partners. Their speaking engagements covered topics like automotive and data centers. 5

But the upside scenario isn’t without its usual risks. Synopsys has dealt with U.S. export restrictions related to China before, and any fresh crackdowns could impact a key market for the EDA sector. 6

Investors are set to watch for updates on demand and integration when Synopsys takes the stage at the 28th Annual Needham Growth Conference on Jan. 15 at 11:15 a.m. PT, as noted in its investor events calendar. 7

Macro data might take the lead. The upcoming U.S. inflation reports feature the Consumer Price Index for December 2025, due Tuesday, Jan. 13, followed by the Producer Price Index for November 2025 on Wednesday, Jan. 14. These figures could shift rate expectations and, in turn, impact high-multiple tech shares. 8

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Valero Energy (VLO) stock slides as Venezuela oil moves and analyst targets reset ahead of earnings
Previous Story

Valero Energy (VLO) stock slides as Venezuela oil moves and analyst targets reset ahead of earnings

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next
Next Story

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Go toTop